Advertisement

Advertisement

End-of-Life Oncology

Advertisement

Advertisement



Nov
19
Today In Oncology
Study Finds Sexual Health Issues Are a Concern Among Majority of Women With Breast Cancer
Factors Influencing Freedom From Distant Recurrence in Premenopausal Women With HR-Positive, HER2-Negative Breast Cancer
Do Poorly Differentiated Clusters in Liver Metastases From Colorectal Cancer Offer Prognostic Value?
2019 Annual Meeting of the American Thyroid Association Briefs
Activity of Tipifarnib in Patients With HRAS-Mutant Head and Neck Squamous Cell Carcinoma
View More 
Advertisement
Most Read Stories
Nivolumab Plus Bevacizumab in Relapsed Ovarian Cancer
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): 2016 Guidelines
Dexamethasone Plus Exercise May Reduce Fatigue in Patients With Advanced Cancer
FDA Grants Accelerated Approval to Zanubrutinib for Pretreated Mantle Cell Lymphoma
Early Lung Cancer Detection Followed by Minimally Invasive Surgery Saves Lives
View More 
Most Viewed Videos
Paolo A. Ascierto, MD, on Melanoma: Results From CheckMate 238 on Adjuvant Nivolumab vs Ipilimumab
Nitin Jain, MD, on CLL: Is There a Role for Chemoimmunotherapy?
Martee L. Hensley, MD, on Leiomyosarcoma: Results From a GOG Treatment Trial
Ana Maria Arance Fernandez, MD, PhD, on Advanced Melanoma: Treatment With Cobimetinib/Atezolizumab vs Pembrolizumab
Sherene Loi, MD, PhD, and Leisha A. Emens, MD, PhD, on HER2-Positive Breast Cancer: KATE2 Study of Atezolizumab/Trastuzumab Emtansine
View More 
© 2019 HSP News Service, L.L.C.